Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis M Santoni, A Rizzo, J Kucharz, V Mollica, M Rosellini, A Marchetti, ... Cancer Immunology, Immunotherapy 72 (6), 1365-1379, 2023 | 125 | 2023 |
Factors affecting sexual function and body image of early-stage breast cancer survivors in Poland: a short-term observation R Kowalczyk, K Nowosielski, I Cedrych, M Krzystanek, I Glogowska, ... Clinical breast cancer 19 (1), e30-e39, 2019 | 96 | 2019 |
Markers of glomerular and tubular damage in the early stage of kidney disease in type 2 diabetic patients A Żyłka, P Dumnicka, B Kuśnierz-Cabala, A Gala-Błądzińska, ... Mediators of inflammation 2018 (1), 7659243, 2018 | 65 | 2018 |
Contemporary treatment of metastatic renal cell carcinoma P Wiechno, J Kucharz, M Sadowska, W Michalski, B Sikora-Kupis, ... Medical Oncology 35, 1-11, 2018 | 57 | 2018 |
High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience I Filipczak-Bryniarska, RM Krzyzewski, J Kucharz, ... Medical Oncology 34, 1-5, 2017 | 49 | 2017 |
Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients A Buda-Nowak, J Kucharz, P Dumnicka, M Kuzniewski, RM Herman, ... Medical Oncology 34, 1-4, 2017 | 43 | 2017 |
Bradycardia as a rare symptom of cisplatin cardiotoxicity: A case report J Kucharz, A Michalowska‑Kaczmarczyk, AL Zygulska, J Wojtak, W Pawlik, ... Oncology letters 11 (3), 2297-2299, 2016 | 28 | 2016 |
Markers of glomerular and tubular damage in the early stage of kidney disease in type 2 diabetic patients A Zylka, P Dumnicka, B Kusnierz-Cabala, A Gala-Bladzinska, ... Mediators of Inflammation 2018, 2018 | 26 | 2018 |
Lack of antiretroviral therapy is associated with higher risk of neurosyphilis among HIV-infected patients who remain serofast after therapy for early syphilis M Pastuszczak, M Sitko, M Bociaga-Jasik, J Kucharz, A Wojas-Pelc Medicine 97 (45), e13171, 2018 | 21 | 2018 |
Serum uromodulin levels in prediction of acute kidney injury in the early phase of acute pancreatitis B Kuśnierz-Cabala, A Gala-Błądzińska, M Mazur-Laskowska, P Dumnicka, ... Molecules 22 (6), 988, 2017 | 21 | 2017 |
Co-occurring adverse events enable early prediction of progression-free survival in metastatic renal cell carcinoma patients treated with sunitinib: a hypothesis-generating study J Kucharz, P Dumnicka, M Kuzniewski, B Kusnierz-Cabala, RM Herman, ... Tumori Journal 101 (5), 555-559, 2015 | 21 | 2015 |
Chemotherapy-induced takotsubo syndrome M Budnik, J Kucharz, P Wiechno, T Demkow, J Kochanowski, E Górska, ... Clinical Pulmonary Research, 19-29, 2018 | 19 | 2018 |
Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor PJ Wiechno, M Kowalska, J Kucharz, M Sadowska, W Michalski, ... Medical Oncology 34, 1-8, 2017 | 19 | 2017 |
Serum copeptin and copeptin/NT-proBNP ratio—new tools to differentiate takotsubo syndrome from acute myocardial infarction M Budnik, S Białek, M Peller, A Kiszkurno, J Kochanowski, J Kucharz, ... Folia medica cracoviensia, 5-13-5-13, 2020 | 18 | 2020 |
Sex‑dependent differences in clinical characteristics and in‑hospital outcomes in patients with takotsubo syndrome T Rosa Polskie Archiwum Medycyny Wewnętrznej 130 (1), 25-30, 2020 | 16 | 2020 |
Dose–volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer Ł Kuncman, K Stawiski, M Masłowski, J Kucharz, J Fijuth Strahlentherapie und Onkologie 196, 998-1005, 2020 | 15 | 2020 |
The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC) J Kucharz, P Dumnicka, B Kusnierz-Cabala, T Demkow, P Wiechno Medical Oncology 36, 1-6, 2019 | 15 | 2019 |
Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma J Kucharz, A Giza, P Dumnicka, M Kuzniewski, B Kusnierz-Cabala, ... Medical Oncology 33, 1-7, 2016 | 14 | 2016 |
Mass spectrometry-based metabolomic profiling of prostate cancer-a pilot study K Ossoliński, J Nizioł, A Arendowski, A Ossolińska, T Ossoliński, ... J. Cancer Metastasis Treat 5 (1), 2019 | 12 | 2019 |
Use of high-dose oxycodone hydrochloride in patients with visceral and neuropathic pain J Kucharz, I Filipczak-Bryniarska, A Michalowska-Kaczmarczyk, ... Contemporary Oncology/Współczesna Onkologia 19 (3), 257-259, 2015 | 12 | 2015 |